Pharmamarketeer

Departing FDA officials say it’s too soon for COVID-19 boosters as White House plans rollout next week

Departing FDA officials say it’s too soon for COVID-19 boosters as White House plans rollout next week

Does the general U.S. population need COVID-19 boosters? A group of renowned global health experts, including two key departing vaccine authorities at the FDA, don’t think so.

Even with the wave of delta variant-driven coronavirus cases in the U.S., the authorized vaccines appear to be staving off severe infections, according to a paper published in The Lancet. The group of authors includes top officials with the World Health Organization.

Departing FDA officials say it’s too soon for COVID-19 boosters as White House plans rollout next week | FiercePharma

Advertentie(s)